Harry Glorikian - Net Worth and Insider Trading

Harry Glorikian Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Harry Glorikian owns 1 companies in total, including Interpace Biosciences Inc (IDXG) .

Click here to see the complete history of Harry Glorikian’s form 4 insider trades.

Insider Ownership Summary of Harry Glorikian

Ticker Comapny Transaction Date Type of Owner
IDXG Interpace Biosciences Inc 2016-01-01 director

Harry Glorikian Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Harry Glorikian Ownership Network

Ownership Network List of Harry Glorikian

No Data

Ownership Network Relation of Harry Glorikian

Insider Network Chart

Harry Glorikian Owned Company Details

What does Interpace Biosciences Inc do?

Who are the key executives at Interpace Biosciences Inc?

Harry Glorikian is the director of Interpace Biosciences Inc. Other key executives at Interpace Biosciences Inc include Principal Financial Officer Christopher Mccarthy , director & President and CEO Thomas W. Burnell , and 10 percent owner Peter H Kamin .

Interpace Biosciences Inc (IDXG) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Interpace Biosciences Inc (IDXG) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Interpace Biosciences Inc (IDXG) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Interpace Biosciences Inc (IDXG)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Interpace Biosciences Inc Insider Transactions

No Available Data

Harry Glorikian Mailing Address

Above is the net worth, insider trading, and ownership report for Harry Glorikian. You might contact Harry Glorikian via mailing address: C/o Interpace Diagnostics Group, Inc., 300 Interpace Parkway, Bldg. A., Parsippany Nj 07054.

Discussions on Harry Glorikian

No discussions yet.